Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Donna L. Dehn"'
Autor:
Andrea Di Francesco, Donald S. Backos, David Ross, Nichole Reisdorph, David Siegel, Donna L. Dehn, Kevin Quinn, Michel Bernier, Rafael de Cabo
Publikováno v:
The FASEB Journal. 32
Autor:
Loretta Gaido, Donna L. Dehn, Petra Homer, Chesney Thompson, Kenneth R. Shroyer, Panduka Samarawardana, Kathleen C. Torkko, Meenakshi Singh, Douglas Franquemont, Vipul Nayi, Stephanie Burke, Matthew A. Titmus
Publikováno v:
Cancer Cytopathology. 118:146-156
BACKGROUND The primary goal of this study was to compare the clinical performance of an optimized and rigorously controlled immunocytochemical (ICC) assay for p16INK4a to high-risk (HR) human papillomavirus (HPV) detection by polymerase chain reactio
Autor:
Donna L. Dehn, T. Miyatake, Barbara Tringler, Jackie Papkoff, Takayuki Enomoto, Ashanta Swisher, Shu-Hui Liu, Kathleen C. Torkko, Kenneth R. Shroyer, Wenhui Liu
Publikováno v:
Gynecologic Oncology. 106:119-127
Objectives and methods B7-H4 (DD-O110), a member of the B7 family, negatively regulates T cell-mediated immune response. Previous studies have shown that B7-H4 is highly expressed in endometrioid ovarian cancers with relatively low levels of expressi
Publikováno v:
Cancer. 111:1-14
Cervical cancer is the second most common cancer in women worldwide. Human papillomavirus (HPV) is the etiologic agent for the vast majority of premalignant and malignant lesions, and high-risk HPV types can be detected in almost all cases of cervica
Publikováno v:
Clinical Cancer Research. 10:3147-3155
Purpose: The purpose of our study was to develop and validate an isogenic cell line pair that differs only in the expression of NAD(P)H:quinone oxidoreductase (NQO1) that can be used to examine the in vitro and in vivo role of NQO1 in the bioactivati
Autor:
David Siegel, Preecha Boonchoong, Lawrence J. Berliner, David Ross, Jin Yi Han, Daniel L. Gustafson, Donna L. Dehn
Publikováno v:
Molecular Pharmacology. 65:1238-1247
Experiments using purified recombinant human NAD(P)H:quinone oxidoreductase 1 (NQO1) revealed that the auto-oxidation of fully reduced protein resulted in a 1:1 stoichiometry of oxygen consumption to NADH oxidation with the production of hydrogen per
Autor:
David Siegel, David Ross, Luo Jia Tang, Jadwiga K. Kepa, Donna L. Dehn, Adil Anwar, Jennifer A. Pietenpol
Publikováno v:
Journal of Biological Chemistry. 278:10368-10373
NAD(P)H:quinone oxidoreductase 1 (NQO1) has been proposed to stabilize p53 via a redox mechanism involving oxidation of NAD(P)H as a consequence of the catalytic activity of NQO1. We report that treatment of HCT-116 human colon carcinoma cells with t
Autor:
Christopher J. Moody, Donna L. Dehn, John Butler, David Ross, Shannon L. Winski, Elizabeth Swann, Robert H J Hargreaves
Publikováno v:
Biochemical Pharmacology. 61:1509-1516
To investigate the importance of NAD(P)H:quinone oxidoreductase 1 (or DT-diaphorase; NQO1) in the bioactivation of antitumor quinones, we established a series of stably transfected cell lines derived from BE human colon adenocarcinoma cells. BE cells
Autor:
S. Mark Roe, Chrisostomos Prodromou, Chuan-Hsin Chang, Rui Xiong, Christopher J. Moody, David Siegel, Russell R. A. Kitson, Huw E. L. Williams, Donna L. Dehn, David Ross, Adrienne L. Davis, William Lewis
Publikováno v:
Nature chemistry. 5(4)
The benzoquinone ansamycin geldanamycin and its derivatives are inhibitors of heat shock protein Hsp90, an emerging target for novel therapeutic agents both in cancer and in neurodegeneration. However, the toxicity of these compounds to normal cells
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 334(1)
NAD(P)H:quinone oxidoreductase 1 (NQO1) deficiency resulting from a homozygous NQO1*2 polymorphism has been associated with an increased risk of benzene-induced myeloid toxicity and a variety of de novo and therapy-induced leukemias. Endothelial cell